Cabenuva vs Apretude
A side-by-side look at two hiv medications advertised on TV. Informational only — not medical advice.
Maintained by TVPills Editorial Team · Site updated November 4, 2026 (not a product-label review)
| Attribute | US Cabenuva | US Apretude |
|---|---|---|
| Generic name | cabotegravir/rilpivirine Unverified catalogue summary (Generic name) for Cabenuva in US; not checked against current local product information. | cabotegravir Unverified catalogue summary (Generic name) for Apretude in US; not checked against current local product information. |
| Drug class | See official local label Unverified catalogue summary (Drug class) for Cabenuva in US; not checked against current local product information. | See official local label Unverified catalogue summary (Drug class) for Apretude in US; not checked against current local product information. |
| Treats | HIV-1 infection Unverified catalogue summary (Treats) for Cabenuva in US; not checked against current local product information. | HIV prevention (PrEP) Unverified catalogue summary (Treats) for Apretude in US; not checked against current local product information. |
| Category | HIV Unverified catalogue summary (Category) for Cabenuva in US; not checked against current local product information. | HIV Unverified catalogue summary (Category) for Apretude in US; not checked against current local product information. |
| Manufacturer | ViiV Healthcare Unverified catalogue summary (Manufacturer) for Cabenuva in US; not checked against current local product information. | ViiV Healthcare Unverified catalogue summary (Manufacturer) for Apretude in US; not checked against current local product information. |
| Year approved | — Unverified catalogue summary (Year approved) for Cabenuva in US; not checked against current local product information. | — Unverified catalogue summary (Year approved) for Apretude in US; not checked against current local product information. |
| Catalogue warning level | Safety summary withheld — check official label Unverified catalogue summary (Catalogue warning level) for Cabenuva in US; not checked against current local product information. | Safety summary withheld — check official label Unverified catalogue summary (Catalogue warning level) for Apretude in US; not checked against current local product information. |
| Est. TV ad spend | — | — |
| Side effects and serious risks | — Unverified catalogue summary (Side effects and serious risks) for Cabenuva in US; not checked against current local product information. | — Unverified catalogue summary (Side effects and serious risks) for Apretude in US; not checked against current local product information. |
Sources and editorial standards
Use the current DailyMed labels to verify approved uses, boxed warnings, and side effects for each medication. Label results can differ by product, strength, and formulation.
Page updated November 4, 2026; the linked resources have not necessarily been reviewed on this date.
Frequently asked questions
Is Cabenuva or Apretude better?
This directory does not compare clinical effectiveness or safety. Listing Cabenuva and Apretude together does not establish shared approved indications, equivalence or suitability as substitutes. Consult the correct local labels and your prescriber.
What's the difference between Cabenuva and Apretude?
The table shows catalogue identification and estimated advertising information for Cabenuva and Apretude, not a verified medical comparison. Medical descriptions, mechanisms and safety summaries are withheld.
Which one spends more on TV ads?
Cabenuva has the larger estimated TV advertising budget of the two.